Search research articles
Contact Us
Filters
Showing results (71-80 of 87) with videos related to
Page
of 9
Sort By:
Domestic Animal Endocrinology
|
November 9, 2025
Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs
Jean Vitor Bondavalli, Monike Willemin Quirino, Neida Conrad, et al.
Targeted Oncology
|
September 16, 2024
Evaluation of Drug-Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
Marie-Emilie Willemin, Jue Gong, Brandi W Hilder, et al.
Arthritis Care & Research
|
September 17, 2016
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
I Kone-Paut, P Quartier, O Fain, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
November 27, 2018
Language lateralisation measured across linguistic and national boundaries
Markus Hausmann, Marc Brysbaert, Lise van der Haegen, et al.
Clinical Pharmacology and Therapeutics
|
September 26, 2023
Utilization of OATP1B Biomarker Coproporphyrin-I to Guide Drug-Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry
Ryota Kikuchi, Paresh P Chothe, Xiaoyan Chu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 4, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab
Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, et al.
Clinical Pharmacokinetics
|
April 11, 2021
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions
Marie-Emilie Willemin, Thomas K Van Der Made, Ils Pijpers, et al.
La Revue De Medecine Interne
|
October 15, 2021
[Telomeropathies: A study of 15 cases]
P Antoine, L Terriou, G Lefèvre, et al.
NPJ Genomic Medicine
|
June 17, 2022
Possible association of 16p11.2 copy number variation with altered lymphocyte and neutrophil counts
Giuliana Giannuzzi, Nicolas Chatron, Katrin Mannik, et al.
Environmental Sciences Europe
|
February 13, 2025
Unmute biodiversity risks of free trade? The EFTA-Mercosur Agreement (Swiss) case study
Rémi Willemin, Cornelia B Krug, Nicolas Roux, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 87) with videos related to
Sort By:
Page
of 9
Domestic Animal Endocrinology
|
November 9, 2025
Immunogenicity of recombinant gonadotropin-releasing hormone contraceptive vaccines in male pigs
Jean Vitor Bondavalli, Monike Willemin Quirino, Neida Conrad, et al.
Targeted Oncology
|
September 16, 2024
Evaluation of Drug-Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
Marie-Emilie Willemin, Jue Gong, Brandi W Hilder, et al.
Arthritis Care & Research
|
September 17, 2016
Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
I Kone-Paut, P Quartier, O Fain, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
|
November 27, 2018
Language lateralisation measured across linguistic and national boundaries
Markus Hausmann, Marc Brysbaert, Lise van der Haegen, et al.
Clinical Pharmacology and Therapeutics
|
September 26, 2023
Utilization of OATP1B Biomarker Coproporphyrin-I to Guide Drug-Drug Interaction Risk Assessment: Evaluation by the Pharmaceutical Industry
Ryota Kikuchi, Paresh P Chothe, Xiaoyan Chu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
June 4, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab
Marie-Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, et al.
Clinical Pharmacokinetics
|
April 11, 2021
Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions
Marie-Emilie Willemin, Thomas K Van Der Made, Ils Pijpers, et al.
La Revue De Medecine Interne
|
October 15, 2021
[Telomeropathies: A study of 15 cases]
P Antoine, L Terriou, G Lefèvre, et al.
NPJ Genomic Medicine
|
June 17, 2022
Possible association of 16p11.2 copy number variation with altered lymphocyte and neutrophil counts
Giuliana Giannuzzi, Nicolas Chatron, Katrin Mannik, et al.
Environmental Sciences Europe
|
February 13, 2025
Unmute biodiversity risks of free trade? The EFTA-Mercosur Agreement (Swiss) case study
Rémi Willemin, Cornelia B Krug, Nicolas Roux, et al.
Page
of 9